Spleen tyrosine kinase as a novel candidate tumor suppressor gene for human oral squamous cell carcinoma

International Journal of Cancer

Volumn 124, Issue 11, 2009, Pages 2651-2657

  Ogane, Satoru ^a   Onda, Takeshi ^a   Takano, Nobuo ^a   Yajima, Tetsuo ^a   Uchiyama, Takeshi ^a   Shibahara, Takahiko ^a  

^a TOKYO DENTAL COLLEGE   (Japan)

Author keywords

Hypermethylation; Oral squamous cell carcinoma; Syk; Transfection

Indexed keywords

MESSENGER RNA; PROTEIN KINASE SYK; PROTEIN TYROSINE KINASE; SIGNAL PEPTIDE;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CELL INVASION; CELL MOTILITY; CERVICAL LYMPH NODE; COMPETITIVE INHIBITION; CONTROLLED STUDY; CPG ISLAND; DEMETHYLATION; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; LYMPH NODE METASTASIS; MALE; METHYLATION; MOUTH CARCINOMA; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN; SQUAMOUS CELL CARCINOMA; SYK GENE; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING; WOUND HEALING; DNA METHYLATION; GENETICS; MIDDLE AGED; MOUTH TUMOR; MUTATION; PATHOLOGY; TUMOR CELL LINE;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DNA METHYLATION; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; MUTATION; PROTEIN-TYROSINE KINASES;

EID: 64249153223     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.24237     Document Type: Article

References (30)

1. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer. J Clin 2000;50:7-33.
2. Yuan YF, Mendez R, Sahin A, Dai JL. Hypermethylation leads to silencing of the SYK gene in human breast cancer. Cancer Res 2001;61:5558-5561 (Pubitemid 32694942)
3. Coopman PJ, Do MT, Barth M, Bowden ET, Hayes AJ, Basyuk E, Blancato JK, Vezza PR, McLeskey SW, Mangeat PH, Mueller SC. The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells. Nature 2000;406:742-747
4. Toyama T, Iwase H, Yamashita H, Hara Y, Omoto Y, Sugiura H, Zhang Z, Fujii Y. Reduced expression of the Syk gene is correlated with poor prognosis in human breast cancer. Cancer Lett 2003;189:97-102. (Pubitemid 35351524)
5. Endo Y, Uzawa K, Mochida Y, Shiiba M, Bukawa H, Yokoe H, Tanzawa H. Sarcoendoplasmic reticulum Ca(2+) ATPase type 2 downregulated in human oral squamous cell carcinoma. Int J Cancer 2004;110:225-231
6. Onda T, Uzawa K, Endo Y, Bukawa H, Yokoe H, Shibahara T, Tanzawa H. Ubiquitous mitochondrial creatine kinase downregulated in oral squamous cell carcinoma. Br J Cancer 2006;94:698-709. (Pubitemid 43361902)
7. Wahi PN. Histological typing of oral and oropharyngeal tumours. International histological classification of tumours, 4th edn. Geneva: World Health Organization, 1971.9-28.
8. Hermanek P, Sobin LH, eds. TNM classification of malignant tumours, 4th edn. Berlin: Springer-Verlag, 1987.16-18.
9. Uzawa K, Suzuki H, Yokoe H, Tanzawa H, Sato K. Mutational state of p16/CDKN2 and VHL genes in squamous-cell carcinoma of the oral cavity. Int J Oncol 1995;7:895-899
10. Yamamoto N, Uzawa K, Yakushiji T, Shibahara T, Noma H, Tanzawa H. Analysis of the ANA gene as a candidate for the chromosome 21q oral cancer susceptibility locus. Br J Cancer 2001;84: 754-759 (Pubitemid 32275647)
11. Joshi BH, Kawakami K, Leland P, Puri RK. Heterogeneity in interleukin- 13 receptor expression and subunit structure in squamous cell carcinoma of head and neck: differential sensitivity to chimeric fusion proteins comprised of interleukin-13 and a mutated form of Pseudomonas exotoxin. Clin Cancer Res 2002;8:1948-1956 (Pubitemid 34633758)
12. Tao DD, Jiang M, Feng YD, Wu JH, Gong JP. Expression of estrogen receptor in different breast cancer cell lines transfected with estrogen receptor plasmid HEGO5 mediated by FuGENE6. Ai Zheng 2004;23:1166-1170
13. Cho Y, Gorina S, Jeffrey PD, Pavletich NP. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 1994;265:346-355 (Pubitemid 24259959)
14. Tebbutt NC, Giraud AS, Inglese M, Jenkins B, Waring P, Clay FJ, Malki S, Alderman BM, Grail D, Hollande F, Heath JK, Ernst M. Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice. Nat Med 2002;8:1080-1082 (Pubitemid 35175963)
15. Saadoun S, Papadopoulos MC, Hara-Chikuma M, Verkman AS. Impairment of angiogenesis and cell migration by targeted aquaporin- 1 gene disruption. Nature 2005;434:786-792 (Pubitemid 44739524)
16. Conacci-Sorrell M, Kaplan A, Raveh S, Gavert N, Sakurai T, Ben- Ze'ev A. The shed ectodomain of Nr-CAM stimulates cell proliferation and motility, and confers cell transformation. Cancer Res 2005;65:11605-11612
17. Yuan Y, Liu H, Sahin A, Day JL. Reactivation of SYK expression by inhibition of DNA methylation suppresses breast cancer cell invasiveness. Int J Cancer 2005;113:654-659 (Pubitemid 40038744)
18. Goodman PA, Burkhardt N, Juran B, Tibbles HE, Uckun FM. Hypermethylation of the spleen tyrosine kinase promoter in T-lineage acute lymphoblastic leukemia. Oncogene 2003;22:2504-2514 (Pubitemid 36560733)
19. Wang L, Duke L, Zhang PS, Arlinghaus RB, Symmans WF, Sahin A, Mendez R, Dai JL. Alternative splicing disrupts a nuclear localization signal in spleen tyrosine kinase that is required for invasion suppression in breast cancer. Cancer Res 2003;63:4724-4730 (Pubitemid 36951053)
20. Mahabeleshwar GH, Kundu GC. Syk, a protein-tyrosine kinase, suppresses the cell motility and nuclear factor kappa B-mediated secretion of urokinase type plasminogen activator by inhibiting the phosphatidylinositol 3′-kinase activity in breast cancer cells. J Biol Chem 2003;278:6209-6221 (Pubitemid 36800876)
21. Moroni M, Soldatenkov V, Zhang L, Zhang Y, Stoica G, Gehan E, Rashidi B, Singh B, Ozdemirli M, Mueller SC. Progressive loss of Syk and abnormal proliferation in breast cancer cells. Cancer Res 2004;64:7346-7354 (Pubitemid 39372073)
22. Lu J, Lin WH, Chen SY, Longnecker R, Tsai SC, Chen CL, Tsai CH. Syk tyrosine kinase mediates Epstein-Barr virus latent membrane protein 2A-induced cell migration in epithelial cells. J Biol Chem 2006;281:8806-8814 (Pubitemid 43847987)
23. Luangdilok S, Box C, Patterson L, Court W, Harrington K, Pitkin L, Rhŷs-Evans P, O-charoenrat P, Eccles S. Syk tyrosine kinase is linked to cell motility and progression in squamous cell carcinomas of the head and neck. Cancer Res 2007;67:7907-7916 (Pubitemid 47281387)
24. Yuan Y, Wang J, Li J, Wang L, Li M, Yang Z, Zhang C, Dai JL. Frequent epigenetic inactivation of spleen tyrosine kinase gene in human hepatocellular carcinoma. Clin Cancer Res 2006;12:6687-6695 (Pubitemid 44876836)
25. Li J, Sidell N. Growth-related oncogene produced in human breast cancer cells and regulated by Syk protein-tyrosine kinase. Int J Cancer 2005;117:14-20. (Pubitemid 41262755)
26. Wang S, Ding YB, Chen GY, Xia JG, Wu ZY. Hypermethylation of Syk gene in promoter region associated with oncogenesis and metastasis of gastric carcinoma. World J Gastroenterol 2004;10:1815-1818 (Pubitemid 38931212)
27. Jones PA, Laird PW. Cancer epigenetics comes of age. Nat Genet 1999;21:163-167 (Pubitemid 29070360)
28. Saito Y, Takazawa H, Uzawa K, Tanzawa H, Sato K. Reduced expression of E-cadherin in oral squamous cell carcinoma: relationship with DNA methylation of 50 CpG island. Int J Oncol 1998;12:293-298 (Pubitemid 28064850)
29. Miracca EC, Kowalski LP, Nagai MA. High prevalence of p16 genetic alterations in head and neck tumours. Br J Cancer 1999;81:677-683 (Pubitemid 29458865)
30. Shintani S, Nakahara Y, Mihara M, Ueyama Y, Matsumura T. Inactivation of the p14ARF, p15INK4B and p16INK4A genes is a frequent event in human oral squamous cell carcinomas. Oral Oncol 2001;37:498-504.